Publications by authors named "Alessandra Mosca"

Claim this Profile
L
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer.
Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, Francesco Orlando, Yari Ciani, Alessandra Mosca

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vibostolimab Coformulated with Pembrolizumab in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: KEYNOTE-365 Cohort G.
Peter C Fong, Mariusz Kwiatkowski, Alessandra Mosca, Begona P Valderrama, Chunde Li

Eur Urol Focus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study).
Chiara Ciccarese, Thomas Büttner, Linda Cerbone, Ilaria Zampiva, Fernando Sabino M Monteiro, Alessandra Mosca

Int J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Francesco Massari, Matteo Santoni, Hideki Takeshita, Yohei Okada, Jose Carlos Tapia, Alessandra Mosca

Cancer Immunol Immunother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Matteo Santoni, Sebastiano Buti, Zin W Myint, Marco Maruzzo, Roberto Iacovelli, Alessandra Mosca

Eur Urol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, Yohei Okada, Francesco Massari, Alessandra Mosca

Cancer Immunol Immunother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Alessandra Mosca

Clin Genitourin Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Camillo Porta, Aristotelis Bamias, Roubini Zakopoulou, Zin W Myint, Nicolò Cavasin, Alessandra Mosca

Minerva Urol Nephrol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Alessandra Mosca

Target Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, Veronica Murianni, Marika Cinausero, Alessandra Mosca

Oncologist· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, Lucia Fratino, Sara Elena Rebuzzi, Alessandra Mosca

Curr Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-time intraoperative guidance of the new HIFU Focal-One platform allows to minimize the perioperative adverse events in salvage setting.
Enrico Checcucci, Stefano De Luca, Federico Piramide, Diletta Garrou, Alessandra Mosca

J Ultrasound· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features.
Stefano Barlati, Donato Morena, Gabriele Nibbio, Paolo Cacciani, Paola Corsini, Alessandra Mosca

Schizophr Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Novel Three-Dimensional () Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, Alessandro Volpe, Luca Cima, Alessandra Mosca

J Pers Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
Noemi Massetti, Mirella Russo, Raffaella Franciotti, Davide Nardini, Giorgio Maria Mandolini, Alessandra Mosca

J Alzheimers Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard versus high-dose chemotherapy in mediastinal germ cell tumors: a narrative review.
Emilio Francesco Giunta, Margaret Ottaviano, Alessandra Mosca, Giuseppe Luigi Banna, Pasquale Rescigno

Mediastinum· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics.
Stefano Barlati, Gabriele Nibbio, Donato Morena, Paolo Cacciani, Paola Corsini, Alessandra Mosca

Front Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma.
Matteo Brunelli, Alessandro Tafuri, Luca Cima, Maria Angela Cerruto, Michele Milella, Alessandra Mosca

J Clin Pathol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel.
Giorgia Gurioli, Vincenza Conteduca, Nicole Brighi, Emanuela Scarpi, Umberto Basso, Alessandra Mosca

BMC Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
Ernesto Rossi, Melissa Bersanelli, Alain Jonathan Gelibter, Nicolò Borsellino, Claudia Caserta, Alessandra Mosca

Curr Oncol Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series.
Sebastiano Buti, Melissa Bersanelli, Francesco Massari, Ugo De Giorgi, Orazio Caffo, Alessandra Mosca

World J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.
Susanna Bianchi, Alessandra Mosca, Alberto Dalla Volta, Veronica Prati, Cinzia Ortega

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Prostate Cancers in the Precision Medicine Era.
Emilio Francesco Giunta, Laura Annaratone, Enrico Bollito, Francesco Porpiglia, Matteo Cereda, Alessandra Mosca

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.
Alessandra Mosca, Ugo De Giorgi, Giuseppe Procopio, Umberto Basso, Giacomo Cartenì

Jpn J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.
Vincenza Conteduca, Alessandra Mosca, Nicole Brighi, Ugo de Giorgi, Pasquale Rescigno

Cells· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis